NCT05668052

Brief Summary

this study adopted a cross-sectional study, collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis, so as to provide better clinical guidance.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 27, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 28, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 29, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 29, 2022

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

December 28, 2022

Last Update Submit

December 28, 2022

Conditions

Cross-sectional StudyCOVID-19 Pandemic

Keywords

Cross-sectional studyCOVID-19 Pandemic

Outcome Measures

Primary Outcomes (1)

  • characters of patients with Covid-19

    this study collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis

    baseline

Interventions

questionnaireOTHER

This survey was conducted in Zhejiang Provincial Hospital of Traditional Chinese Medicine from December 2022 to December 2023. The research objects were patients with COVID-19.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with Covid-19

You may qualify if:

  • A positive nucleic acid test for Covid-19, or a positive antigen test for novel coronavirus, no age limit.

You may not qualify if:

  • Unable to understand the contents of the questionnaire for various reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2022

First Posted

December 29, 2022

Study Start

December 27, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 29, 2022

Record last verified: 2022-12